# RVAC Medicines

**Private**  
**Singapore**  
**Healthcare & Life Sciences**  
[https://rvacmed.com](https://rvacmed.com/)

**Last Round**  
Series B  
Apr 26, 2022

**Total Funding Raised**  
$140M

## Company Overview

RVAC Medicines is a biotechnology company that develops an mRNA platform to build a diverse pipeline of innovative vaccines and therapeutics to address unmet medical needs.

**Sector**  
Healthcare & Life Sciences

**Verticals**  
Biotechnology, Drug Discovery

**Business Model**  
B2B

**Customer Profile**  
Services & Consulting

**AI Layer**  
Non-AI

**Keywords**  
mRNA platform, mRNA vaccine, biotech, mRNA therapeutics, drug discovery, lipid nanoparticle, LNP, CMO, contract manufacturing, biopharma, medical countermeasures, vaccine development, clinical-stage biotech, platform biotech

## Historical Pricing

### Unlock Pricing Charts

Historical view of private secondary pricing and transaction trends.

## Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

### View Momentum History

Track how buyer interest and sentiment changes over time.

## RVAC Medicines Comparables

Compare RVAC Medicines with similar companies based on industry and business-model similarity.

| Company | Similarity | Market Cap |
| --- | --- | --- |
| [Innorna](/content/company/innorna/index.html) | 88% | Unlock |
| [Immorna Biotherapeutics](/content/company/immornabio/index.html) | 83% | Unlock |
| [Strand Therapeutics](/content/company/strand-therapeutics/index.html) | 79% | Unlock |
| Comparable company | 50% | Unlock |

## RVAC Medicines Funding Rounds

Historical fundraising activity

| Round | Date | Amount Raised | Valuation | Investors | Sources |
| --- | --- | --- | --- | --- | --- |
| Series B | Apr 26, 2022 | Unlock | Unlock | Unlock | Unlock |

## RVAC Medicines Investors

Notable investors and investment history

| Investor | Rounds |
| --- | --- |
| [CBC Group](/content/investor/cbridgecap/index.html) | Series B |
| [EDBI](/content/investor/edbi/index.html) | Series B |
| [Pavilion Capital](/content/investor/pavcap-com/index.html) | Series B |
| [GS Holdings](/content/investor/gsholdings-com/index.html) | Series B |

## RVAC Medicines Filings

SEC and related filings with document metadata.

| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
| --- | --- | --- | --- | --- | --- | --- |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |

## Frequently Asked Questions

- Is RVAC Medicines a public or private company?
- What is the current stock price of RVAC Medicines?
- How much is RVAC Medicines worth (valuation)?
- Can I buy RVAC Medicines stock?
- When was RVAC Medicines's last funding round?
- Who are the main investors in RVAC Medicines?
- Will RVAC Medicines IPO soon?
- How can I track RVAC Medicines secondary market activity?

## Firmographic Details

- **Headquarters**: Singapore  
- **Employee Range**: 17  
- **Year Founded**: 2021  
- **Last Funding**: Apr 26, 2022